The tuberculosis emergency in eastern Europe

The Lancet HIV

Volumn 3, Issue 3, 2016, Pages e107-e108

  Furin, Jennifer ^a,b   Isaakidis, Petros ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE TRANSMISSION; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; EASTERN EUROPE; EMERGENCY HEALTH SERVICE; HEALTH CARE PLANNING; HUMAN; MORTALITY; NOTE; PRIORITY JOURNAL; TUBERCULOSIS; EUROPE; HIV INFECTIONS; INCIDENCE; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION;

TUBERCULOSTATIC AGENT;

ANTITUBERCULAR AGENTS; EUROPE; EUROPE, EASTERN; HIV INFECTIONS; HUMANS; INCIDENCE; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION;

EID: 84959183329     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(16)00002-3     Document Type: Note

References (14)

1. Global Tuberculosis Report 2015 2015, WHO, World Health Organization, Geneva.
2. Podlekareva DN, Efsen AMW, Schultze A, et al. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study. Lancet HIV 2016, the TB:HIV study group in EuroCoord, published online Feb 1. http://dx.doi.org/10.1016/S2352-3018(15)00252-0.
3. Isaakidis P, Casas ECC, Das M, et al. Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis. Int J Tuberc Lung Dis 2015, 19:969-978.
4. Farmer P Infections and inequalities: the modern plagues 1999, University of California Press, Berkley.
5. Keshavjee S, Dowdy D, Swaminathan S Stopping the body count: a comprehensive approach to move towards zero tuberculosis deaths. Lancet 2015, published online Oct 26. http://dx.doi.org/10.1016/S0140-6736(15)00319-0.
6. Hiasihri S, Aia P, John NL, et al. Primary transmission of drug-resistant tuberculosis in South Fly District, Western Province, Papua New Guinea. 46th Union World Conference on Lung Health; Cape Town, South Africa; Dec 2-6, 2015.
7. Isaakidis P, Das M, Kumar AMV, et al. Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India. PLoS One 2014, 9:e110461.
8. Shah NS, Brust J, Mathema B, et al. Majority of XDR TB cases are due to transmission in a high-HIV-prevalence setting. Conference on Retroviruses and Opportunistic Infections; Seattle, WA, USA; Feb 23-26, 2015. Abstract 92.
9. Sigaloff K, Lange J, Montaner J Global response to HIV: treatment as prevention or treatment for treatment. Clin Infect Dis 2014, 59(suppl 1):S7-S11.
10. Lessem E, Cox H, Daniels C, et al. Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives. Int J Infect Dis 2014, 32:56-60.
11. Seddon JA, Fred D, Amanullah F, et al. Post-exposure management of multidrug-resistant tuberculosis contacts: evidence-based recommendations. Policy Brief No. 1 2015, Harvard Medical School Center for Global Health Delivery-Dubai, Dubai.
12. Frick M, von Delft D, Kumar B End stigmatizing language in tuberculosis research and practice. BMJ 2015, 350:h1479.
13. Daftary A, Padayatchi N, O'Donnell M Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa. Glob Public Health 2014, 9:1107-1116.
14. Chan M Learning from Ebola: readiness for outbreaks and emergencies. Bull World Health Organ 2015, 93:818. 18A.